Source: Brazilian Journal of Microbiology. Unidade: FCF
Subjects: MYCOBACTERIUM TUBERCULOSIS, TUBERCULOSE
ABNT
MIYATA, Marcelo et al. Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the succeptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs. Brazilian Journal of Microbiology, v. 44, n. 1, p. 281-285, 2012Tradução . . Disponível em: https://doi.org/10.1590/s1517-83822013005000028. Acesso em: 21 out. 2024.APA
Miyata, M., Pavan, F. R., Sato, D. N., Marino, L. B., Hirata, M. H., Cardoso, R. F., et al. (2012). Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the succeptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs. Brazilian Journal of Microbiology, 44( 1), 281-285. doi:10.1590/s1517-83822013005000028NLM
Miyata M, Pavan FR, Sato DN, Marino LB, Hirata MH, Cardoso RF, Melo FAF de, Leite CQF. Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the succeptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs [Internet]. Brazilian Journal of Microbiology. 2012 ; 44( 1): 281-285.[citado 2024 out. 21 ] Available from: https://doi.org/10.1590/s1517-83822013005000028Vancouver
Miyata M, Pavan FR, Sato DN, Marino LB, Hirata MH, Cardoso RF, Melo FAF de, Leite CQF. Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the succeptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs [Internet]. Brazilian Journal of Microbiology. 2012 ; 44( 1): 281-285.[citado 2024 out. 21 ] Available from: https://doi.org/10.1590/s1517-83822013005000028